To require the Commissioner of Food and Drugs to make available for public inspection all records of information submitted to the Food and Drug Administration in conjunction with authorizing the emergency use of, or licensing, a COVID-19 vaccine.

Bill: 117-hr-6133
Sponsor: full_name: Rep. Norman, Ralph [R-SC-5]
Introduced: 2021-12-02
Policy area: Health
Subjects: Cardiovascular and respiratory health

Drug safety, medical device, and laboratory regulation

Emergency medical services and trauma care

Government information and archives

Immunology and vaccination

Infectious and parasitic diseases

Licensing and registrations
Latest action: action_date: 2021-12-03
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2021-12-02
action_desc: Introduced in House
text: <p>This bill requires the Food and Drug Administration (FDA) to make publicly available all records of information submitted to the FDA in conjunction with the emergency use authorization or licensing of a COVID-19 vaccine.</p>

tv_txt: I 117th CONGRESS 1st Session H. R. 6133 IN THE HOUSE OF REPRESENTATIVES December 2, 2021 Mr. Norman (for himself, Mr. Massie , Mr. Duncan , Mr. Perry , Mr. Roy , Mr. Good of Virginia , Mr. Webster of Florida , Mrs. Miller of Illinois , Mr. Weber of Texas , Mr. Cawthorn , Mr. Posey , Mr. Bishop of North Carolina , Mr. Gohmert , Mr. Gosar , Mr. Babin , and Mrs. Greene of Georgia ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To require the Commissioner of Food and Drugs to make available for public inspection all records of information submitted to the Food and Drug Administration in conjunction with authorizing the emergency use of, or licensing, a COVID–19 vaccine.

1. Public disclosure of information submitted to FDA for authorizing emergency use of, or licensing, any COVID–19 vaccine Not later than 100 days after the date of enactment of this Act, the Commissioner of Food and Drugs shall make available for public inspection all records of information submitted to the Food and Drug Administration in conjunction with authorizing the emergency use of, or licensing, a COVID–19 vaccine.